Home
Zydus Cadila

Zydus Cadila Market Share Analysis for November 2025

Health > Biotechnology and Pharmaceuticals

Domainzyduscadila.com

Year Founded1952

Employees> 10001

Annual Revenue> $1B

Zydus Cadila

Showing Zydus Cadila's traffic and engagement information for its main website (including company regionals)

zyduscadila.com
zydususa.com

See more website traffic and engagement information

Zydus Cadila Revenue up to November 2025 is > 1B

revenue generated by Zydus Cadila top domains

Zydus Cadila top domains revenue over 3 years

Revenue for Zydus Cadila top domains

zyduscadila.com> 1B

zydususa.com500M - 1B

See more with Sales Intelligence

Total visits to Zydus Cadila's top domains

Understand Zydus Cadila market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zyduscadila.com18.4K

zydususa.com14.8K

See more with Sales Intelligence

Avg. visit duration in Zydus Cadila's top domains

Analyze Zydus Cadila engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zyduscadila.com00:03:57

zydususa.com00:01:51

See more with Sales Intelligence

Avg. pageviews on Zydus Cadila's top domains

See how Zydus Cadila keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zyduscadila.com3.07

zydususa.com2.75

See more with Sales Intelligence

Zydus Cadila top competitors by domain

Top similar sites in November 2025, ranked by their affinity

cadilapharma.comCompany NameCadila Pharmaceuticals Ltd.Employees5001 - 10000HQIndia, AhmedabadAnnual revenue$15M - $25MTotal visits19.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Zydus Cadila

These are the website technologies, by industry, used by Zydus Cadila top domains

Widget (4)

reCAPTCHA

Advertising (3)

DoubleClick

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

4

See all

News & Signals from Zydus Cadila

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZydus Group launches 10 new products in the US.Zydus launched 10 new products in the US, including gRevlimid in Q2FY23.

NewsZydus Group launched Antibody Drug Conjugate on May 1st '21.For instance, in May 2021, Zydus Cadila, a leading Indian Pharmaceutical company, launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name ‘Ujvira’.